PTC Therapeutics, Inc. (PTCT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about PTC Therapeutics, Inc. (PTCT)
Go deeper and ask any question about PTCT
Company Performance
Current Price
as of Oct 03, 2024$35.37
P/E Ratio
N/A
Market Cap
$2.72B
Description
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Metrics
Overview
- HQWarren, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerPTCT
- Price$35.37-2.91%
Trading Information
- Market Cap$2.72B
- Float96.71%
- Average Daily Volume (1m)705,933
- Average Daily Volume (3m)597,154
- EPS-$6.32
Company
- Revenue$900.45M
- Rev Growth (1yr)-12.68%
- Net Income-$99.18M
- Gross Margin90.15%
- EBITDA Margin-14.11%
- EBITDA-$26.34M
- EV$1.65B
- EV/Revenue1.83
- P/EN/A
- P/S3.01
Documents
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia